Group items tagged

Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands Company, a company owned by American private equity firm Yellow Wood Partners. The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer, valued at around $80 million. Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt. ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024. Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being rigorous and disciplined where there are opportunities for divestment. "While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.

It has been discovered that chemicals and preservatives used in the preservation of canned meat, fish and even fruits, like apples, to give them longer shelf life are toxic to the body and help fibroid growth in women. Also, it has equally been revealed by fertility experts that fertility boosting medications or anything that is high in estrogen will cause fibroid to grow.

"Advances in scientific research have deepened our understanding of the intricate relationship between genetics and cancer. The field of oncogenetics has emerged, shedding light on how genetic factors influence cancer development, progression and response to treatment..." Learn More Here:https://dr-sanjoy-mandal.blogspot.com/2023/06/exploring-role-of-genetics-in-cancer.html